BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 31167532)

  • 1. Identification of key pathways and genes changes in pancreatic cancer cells (BXPC-3) after cross-talked with primary pancreatic stellate cells using bioinformatics analysis.
    Tang D; Wu Q; Yuan Z; Xu J; Zhang H; Jin Z; Zhang Q; Xu M; Wang Z; Dai Z; Fang H; Li Z; Lin C; Shi C; Xu M; Sun X; Wang D
    Neoplasma; 2019 Jun; ():. PubMed ID: 31167532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of key pathways and genes changes in pancreatic cancer cells (BXPC-3) after cross-talk with primary pancreatic stellate cells using bioinformatics analysis.
    Tang D; Wu Q; Yuan Z; Xu J; Zhang H; Jin Z; Zhang Q; Xu M; Wang Z; Dai Z; Fang H; Li Z; Lin C; Shi C; Xu M; Sun X; Wang D
    Neoplasma; 2019 Sep; 66(5):681-693. PubMed ID: 31169017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of key pathways and gene changes in primary pancreatic stellate cells after cross-talk with pancreatic cancer cells (BXPC-3) using bioinformatics analysis.
    Tang D; Wu Q; Yuan Z; Xu J; Zhang H; Jin Z; Zhang Q; Xu M; Wang Z; Dai Z; Fang H; Li Z; Lin C; Shi C; Xu M; Sun X; Wang D
    Neoplasma; 2019 May; 66(3):446-458. PubMed ID: 30784291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying
    Ding J; Liu Y; Lai Y
    PeerJ; 2020; 8():e10419. PubMed ID: 33282565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of potential target genes in pancreatic ductal adenocarcinoma by bioinformatics analysis.
    Tang Y; Zhang Z; Tang Y; Chen X; Zhou J
    Oncol Lett; 2018 Aug; 16(2):2453-2461. PubMed ID: 30013637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
    Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
    Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening and validating the core biomarkers in patients with pancreatic ductal adenocarcinoma.
    Li Y; Zhu YY; Dai GP; Wu DJ; Gao ZZ; Zhang L; Fan YH
    Math Biosci Eng; 2019 Nov; 17(1):910-927. PubMed ID: 31731384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
    Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
    Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of key pathways and candidate genes in pancreatic ductal adenocarcinoma using bioinformatics analysis.
    He Y; Liu Y; Gong J; Liu C; Zhang H; Wu H
    Oncol Lett; 2019 Apr; 17(4):3751-3764. PubMed ID: 30881497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of ASPM, BUB1B and SPDL1 in tumor tissues predicts poor survival in patients with pancreatic ductal adenocarcinoma.
    Tian X; Wang N
    Oncol Lett; 2020 Apr; 19(4):3307-3315. PubMed ID: 32218868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioinformatics analyses of gene expression profile identify key genes and functional pathways involved in cutaneous lupus erythematosus.
    Gao ZY; Su LC; Wu QC; Sheng JE; Wang YL; Dai YF; Chen AP; He SS; Huang X; Yan GQ
    Clin Rheumatol; 2022 Feb; 41(2):437-452. PubMed ID: 34553293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of key pathways and genes in colorectal cancer using bioinformatics analysis.
    Liang B; Li C; Zhao J
    Med Oncol; 2016 Oct; 33(10):111. PubMed ID: 27581154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of key regulators of pancreatic ductal adenocarcinoma using bioinformatics analysis of microarray data.
    Li N; Zhao X; You S
    Medicine (Baltimore); 2019 Jan; 98(2):e14074. PubMed ID: 30633213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of differentially expressed genes regulated by molecular signature in breast cancer-associated fibroblasts by bioinformatics analysis.
    Vastrad B; Vastrad C; Tengli A; Iliger S
    Arch Gynecol Obstet; 2018 Jan; 297(1):161-183. PubMed ID: 29063236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comprehensive meta-analysis of transcriptome data to identify signature genes associated with pancreatic ductal adenocarcinoma.
    Kordshouli SO; Tahmasebi A; Moghadam A; Ramezani A; Niazi A
    PLoS One; 2024; 19(2):e0289561. PubMed ID: 38324544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of genes and pathways associated with pancreatic ductal adenocarcinoma by bioinformatics analyses.
    Long J; Zhang Z; Liu Z; Xu Y; Ge C
    Oncol Lett; 2016 Feb; 11(2):1391-1397. PubMed ID: 26893748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of hub genes and regulators associated with pancreatic ductal adenocarcinoma based on integrated gene expression profile analysis.
    Shang M; Zhang L; Chen X; Zheng S
    Discov Med; 2019 Sep; 28(153):159-172. PubMed ID: 31926587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of key pathways and genes in nasopharyngeal carcinoma using bioinformatics analysis.
    Zhu HM; Fei Q; Qian LX; Liu BL; He X; Yin L
    Oncol Lett; 2019 May; 17(5):4683-4694. PubMed ID: 30988824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Derivation and Validation of the Potential Core Genes in Pancreatic Cancer for Tumor-Stroma Crosstalk.
    Xue R; Hua L; Xu W; Gao Y; Pang Y; Hao J
    Biomed Res Int; 2018; 2018():4283673. PubMed ID: 30519576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KEGG-expressed genes and pathways in triple negative breast cancer: Protocol for a systematic review and data mining.
    Chen J; Liu C; Cen J; Liang T; Xue J; Zeng H; Zhang Z; Xu G; Yu C; Lu Z; Wang Z; Jiang J; Zhan X; Zeng J
    Medicine (Baltimore); 2020 May; 99(18):e19986. PubMed ID: 32358373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.